AP

Can cancer blood tests live up to promise of saving lives?

Apr 10, 2022, 10:16 PM | Updated: Apr 15, 2022, 9:26 am

Joyce Ares sits for a portrait in the dinning room of her home on Friday, March 18, 2022, in Canby,...

Joyce Ares sits for a portrait in the dinning room of her home on Friday, March 18, 2022, in Canby, Ore. When she turned 74, Ares was feeling fine when she agreed to give a blood sample for research. So she was surprised when the screening test came back positive for signs of cancer. After a repeat blood test, a PET scan and a needle biopsy, she was diagnosed with Hodgkin lymphoma. (AP Photo/Nathan Howard)

(AP Photo/Nathan Howard)

Joyce Ares had just turned 74 and was feeling fine when she agreed to give a blood sample for research. So she was surprised when the screening test came back positive for signs of cancer.

After a repeat blood test, a PET scan and a needle biopsy, she was diagnosed with Hodgkin lymphoma.

“I cried,” the retired real estate broker said. “Just a couple of tears and thought, ‘OK, now what do we do?'”

The Canby, Oregon, resident had volunteered to take a blood test that is being billed as a new frontier in cancer screening for healthy people. It looks for cancer by checking for DNA fragments shed by tumor cells.

Such blood tests, called liquid biopsies, are already used in patients with cancer to tailor their treatment and check to see if tumors come back.

Now, one company is promoting its blood test to people with no signs of cancer as a way to detect tumors in the pancreas, ovaries and other sites that have no recommended screening method.

It’s an open question whether such cancer blood tests — if added to routine care — could improve Americans’ health or help meet the White House’s goal of cutting the cancer death rate in half over the next 25 years.

With advances in DNA sequencing and data science making the blood tests possible, California-based Grail and other companies are racing to commercialize them.

And U.S. government researchers are planning a large experiment — with 200,000 participants and possibly lasting seven years — to see if the blood tests can live up to the promise of catching more cancers earlier and saving lives.

“They sound wonderful, but we don’t have enough information,” said Dr. Lori Minasian of the National Cancer Institute, who is involved in planning the research. “We don’t have definitive data that shows that they will reduce the risk of dying from cancer.”

Grail is far ahead of other companies with 2,000 doctors willing to prescribe the $949 test. Most insurance plans don’t cover the cost. The tests are being marketed without endorsements from medical groups or a recommendation from U.S. health authorities.

FDA authorization, clearance or approval of such tests is required by law, but the agency historically has not enforced most regulatory requirements for ones – like Grail’s – that are designed, manufactured and used within a single laboratory. The agency is working with Congress on legislation to update the regulatory framework, which would include active oversight for such tests, said FDA spokesman Jim McKinney.

“For a drug, the FDA demands that there is a substantial high likelihood that the benefits not only are proven, but they outweigh the harms. That’s not the case for devices like blood tests,” said Dr. Barry Kramer of the Lisa Schwartz Foundation for Truth in Medicine.

Grail plans to seek approval from the FDA, but is marketing its test as it submits data to the agency.

The history of cancer screening has taught caution. In 2004, Japan halted mass screening of infants for a childhood cancer after studies found it didn’t save lives. Last year, a 16-year study in 200,000 women in the United Kingdom found regular screening for ovarian cancer didn’t make any difference in deaths.

Cases like these have uncovered some surprises: Screening finds some cancers that don’t need to be cured. The flip side? Many dangerous cancers grow so fast they elude screening and prove deadly anyway.

And screening can do more harm than good. Anxiety from false positives. Unnecessary costs. And serious side effects from cancer care: PSA tests for men can lead to treatment complications such as incontinence or impotence, even when some slow-growing prostate cancers would never have caused trouble.

The evidence is strongest for screening tests for cancers of the breast, cervix and colon. For some smokers, lung cancer screening is recommended.

The recommended tests — mammography, PAP tests, colonoscopy — look for one cancer at a time. The new blood tests look for many cancers at once. That’s an advantage, according to Grail executive Dr. Joshua Ofman.

“We screen for four or five cancers in this country, but (many) cancer deaths are coming from cancers that we’re not looking for at all,” Ofman said.

Dr. Tomasz Beer of Oregon Health & Science University in Portland led the company-sponsored study that Joyce Ares joined in 2020. After a miserable winter of chemotherapy and radiation, doctors told her the treatment was a success.

Her case isn’t an outlier, “but it is the sort of hoped-for ideal outcome, and not everyone is going to have that,” Beer said.

While there were other early cancers detected among study participants, some had less clear-cut experiences. For some, blood tests led to scans that never located a cancer, which could mean the result was a false positive, or it could mean there’s a mystery cancer that will show up later. For others, blood tests detected cancer that turned out to be advanced and aggressive, Beer said. One older participant with a bad case declined treatment.

Grail continues to update its test as it learns from these studies, and is sponsoring a trial with Britain’s National Health Service in 140,000 people to see if the blood test can reduce the number of cancers caught in late stages.

Although Ares feels lucky, it’s impossible to know whether her test added healthy years to her life or made no real difference, said Kramer, former director of the National Cancer Institute’s Division of Cancer Prevention.

“I sincerely hope that Joyce benefited from having this test,” Kramer said when told of her experience. “But unfortunately, we can’t know, at the individual Joyce level, whether that’s the case.”

Cancer treatments can have long-term side effects, he said, “and we don’t know how fast the tumor would have grown.” Treatment for Hodgkin lymphoma is so effective that delaying therapy until she felt symptoms might have achieved the same happy outcome.

For now, health experts stress the Grail blood test is not a cancer diagnosis; a positive result triggers further scans and biopsies.

“This is a path in diagnostic testing that has never been tried before,” Kramer said. “Our ultimate destination is a test that has a clear net benefit. If we don’t do it carefully, we’ll go way off the path.”

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.

___

This story was first published on April 11, 2022. It was updated on April 14, 2022, to make clear that FDA approval of some tests is required by law but the agency historically has not enforced regulatory requirements on certain tests.

Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.


              Vials of blood from a participant in a clinical study of the effectiveness of a new liquid biopsy technology are packaged for shipment at Oregon Health & Science University in Portland, Ore., on March 14, 2022. The clinical trial will follow hundreds of participants for three years to see if signals of any cancers that participants later develop were present in their blood. (AP Photo/Gillian Flaccus)
            
              Jacob Marquez, a clinical research coordinator at Oregon Health & Science University's Knight Cancer Institute in Portland, Ore., draws blood from clinical study participant David Parker on March 14, 2022. Parker is one of hundreds of people participating in a trial for a new liquid biopsy technology that could detect early signs of cancer in a person's blood. (AP Photo/Gillian Flaccus)
            
              Jacob Marquez, a clinical research coordinator at Oregon Health & Science University's Knight Cancer Institute in Portland, Ore., draws blood from a clinical study participant on March 14, 2022. Parker is one of hundreds of people participating in a trial for a new liquid biopsy technology that could detect early signs of cancer in a person's blood. (AP Photo/Gillian Flaccus)
            
              Joyce Ares checks on daffodils in her back garden on Friday, March 18, 2022, in Canby, Ore. She had volunteered to take a blood test that is being billed as a new frontier in cancer screening for healthy people. It looks for cancer by checking for DNA fragments shed by tumor cells. (AP Photo/Nathan Howard)
            
              Joyce Ares stands for a portrait in front of her home on Friday, March 18, 2022, in Canby, Ore. She had volunteered to take a blood test that is being billed as a new frontier in cancer screening for healthy people. It looks for cancer by checking for DNA fragments shed by tumor cells. (AP Photo/Nathan Howard)
            
              Joyce Ares plants a peony bud in her garden on Friday, March 18, 2022, in Canby, Ore. She had volunteered to take a blood test that is being billed as a new frontier in cancer screening for healthy people. It looks for cancer by checking for DNA fragments shed by tumor cells. (AP Photo/Nathan Howard)
            
              Joyce Ares plays with her poodles Gracie, left, and Oliver in the dinning room of her home on Friday, March 18, 2022, in Canby, Ore. She had volunteered to take a blood test that is being billed as a new frontier in cancer screening for healthy people. It looks for cancer by checking for DNA fragments shed by tumor cells. (AP Photo/Nathan Howard)
            
              Joyce Ares sits for a portrait in the dinning room of her home on Friday, March 18, 2022, in Canby, Ore. Although Ares feels lucky, it’s impossible to know whether her cancer blood test added healthy years to her life or made no real difference, said Dr. Barry Kramer , former director of the National Cancer Institute’s Division of Cancer Prevention. “I sincerely hope that Joyce benefited from having this test,” Kramer said when told of her experience. Cancer treatments can have long-term side effects, he said, "and we don’t know how fast the tumor would have grown.” Treatment for Hodgkin lymphoma is so effective that delaying therapy until she felt symptoms might have achieved the same happy outcome. (AP Photo/Nathan Howard)
            
              Joyce Ares grooms her poodle Gracie in the garage on Friday, March 18, 2022, in Canby, Ore. She had volunteered to take a blood test that is being billed as a new frontier in cancer screening for healthy people. It looks for cancer by checking for DNA fragments shed by tumor cells. (AP Photo/Nathan Howard)
            
              Joyce Ares and her poodle Oliver water a recently-planted peony in her back garden on Friday, March 18, 2022, in Canby, Ore. She had volunteered to take a blood test that is being billed as a new frontier in cancer screening for healthy people. It looks for cancer by checking for DNA fragments shed by tumor cells. (AP Photo/Nathan Howard)
            
              Joyce Ares sits for a portrait in the dinning room of her home on Friday, March 18, 2022, in Canby, Ore. When she turned 74, Ares was feeling fine when she agreed to give a blood sample for research. So she was surprised when the screening test came back positive for signs of cancer. After a repeat blood test, a PET scan and a needle biopsy, she was diagnosed with Hodgkin lymphoma. (AP Photo/Nathan Howard)

AP

Ray Epps Ray Epps, an Arizona man who became the center of a conspiracy theory about Jan. 6, 2021, ...

Associated Press

Ray Epps, an Arizona man who supported Trump, pleads guilty to Capital riot charge

Ray Epps, the target of a conspiracy theory about the Jan. 6, 2021, attack, pleaded guilty on Wednesday to a misdemeanor charge.

9 hours ago

Former President Donald Trump repeatedly declined in an interview aired Sunday, Sept. 17, 2023, to ...

Associated Press

Trump refuses to say in a TV interview how he watched the Jan. 6 attack unfold at the US Capitol

Former President Donald Trump repeatedly declined in an interview aired Sunday to answer questions about whether he watched the Capitol riot.

4 days ago

This frame grab from video, provided by the Mexican government, shows Ovidio Guzman Lopez being det...

Associated Press

Mexico extradites son of ‘El Chapo,’ Ovidio Guzman Lopez to US

The son of notorious cartel leader Joaquin “El Chapo” Guzmán, Ovidio Guzman Lopez was extradited to the U.S. on Friday.

4 days ago

impeachments in US history...

Associated Press

A look at notable impeachments in US history, including Texas Attorney General Ken Paxton

Texas Attorney General Ken Paxton was acquitted Saturday on during his impeachment trial. Here's a roundup of impeachments in U.S. history.

4 days ago

The sticker price is displayed in the window of an unsold 2023 Navigator sports-utility vehicle at ...

Associated Press

The auto workers strike will drive up car prices, but not right away — unless consumers panic

Car shoppers are heading for a new round of sticker shock if the strike by the United Auto Workers doesn’t end soon, officials say.

5 days ago

Gov. Michelle Lujan Grisham announces an order restricting people from carrying guns in Bernalillo ...

Associated Press

Group sues after New Mexico governor suspends right to carry guns in Albuquerque in public

The New Mexico governor's emergency order suspending the right to carry firearms in public near Albuquerque drew an immediate court challenge.

11 days ago

Sponsored Articles

Home moving relocation in Arizona 2023...

BMS Moving

Tips for making your move in Arizona easier

If you're moving to a new home in Arizona, use this to-do list to alleviate some stress and ensure a smoother transition to your new home.

...

SCHWARTZ LASER EYE CENTER

Key dates for Arizona sports fans to look forward to this fall

Fall brings new beginnings in different ways for Arizona’s professional sports teams like the Cardinals and Coyotes.

...

DAY & NIGHT AIR CONDITIONING, HEATING AND PLUMBING

Here are the biggest tips to keep your AC bill low this summer

PHOENIX — In Arizona during the summer, having a working air conditioning unit is not just a pleasure, but a necessity. No one wants to walk from their sweltering car just to continue to be hot in their home. As the triple digits hit around the Valley and are here to stay, your AC bill […]

Can cancer blood tests live up to promise of saving lives?